Detail of "18197-26-7"

CAS Number:
18197-26-7
Name:
Formamide, N-formyl-,sodium salt (9CI)
Superlist Name:
Sodium diformylamide
Molecular Structure:
Formula:
C2H3 N O2 . Na
Molecular Weight:
95.03
Synonyms:
Diformamide,sodium salt (8CI); Diformylimide sodium salt; Sodium diformamide; Sodiumdiformylamide
Melting Point:
205°C
Hazard Symbols:
Risk Codes:
R36/37/38
Safety:
Hazard Codes Xi
Risk Statements 36/37/38
Safety Statements 26-36
WGK Germany 3

F 3-9-34
Details

Sodium diformamide

Supplier:TRUST&WE CO.,Ltd. [ China (Mainland)]

620 Integral
620

Tel:+86-021-61551611

Address:No. 317, 219 Nong, Gao Muqiao Road, Zhangjiang Hightech. Park, Pudong, Shanghai

Supplier:ETA SCIENTIFIC Co.,Ltd [ United Kingdom]

600 Integral
600

Tel:44(0)870 288 1408

Address:UNITED KINGDOM

Supplier:su zhou hande sciences [ China (Mainland)]

355 Integral
355

Tel:86-512-88865304

Address:suzhou

570 Integral
570

Tel:02586245551 13851900823

Address:nanjing

Please post your buying leads,so that our qualified suppliers will soon contact you!
*Required Fields

Methods for the Synthesis of 5,6,7,8-Tetrahydro-1,8-naphthyridine Fragments for aVb3 Integrin Antagonists: Some chemicals with cas registry numbers like 111770-82-2 and 18197-26-7 are also used. Methods for the Synthesis of 5,6,7,8-Tetrahydro-1,8-naphthyridine Fragments for aVb3 Integrin Antagonists. Hartner, Frederick W.; Hsiao, Yi; Eng, Kan K.; Rivera, Nelo R.; Palucki, Michael; Tan, Lushi; Yasuda, Nobuyoshi; Hughes, David L.; Weissman, Steven; Zewge, Daniel; King, Tony; Tschaen, Dave; Volante, R. P. ( Department of Process Research, Merck Research Laboratories, Rahway, NJ 07065, USA). Journal of Organic Chemistry, 69(25), 8723-8730 (English) 2004 American Chemical Society. CODEN: JOCEAH. ISSN: 0022-3263. DOCUMENT TYPE: Journal CA Section: 28 (Heterocyclic Compounds (More Than One Hetero Atom)) The prepn. of 3-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)propan-1-amine and 3-[(7R)-7-methyl-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl]propan-1-amin e, key intermediates in the synthesis of aVb3 antagonists, is described. The syntheses rely on the efficient double Sonogashira reactions of 2,5-dibromopyridine with (S)-HOCHRCYCH [R = H, Me] and protected propargylamines followed by Chichibabin cyclizations of 3,3'-pyridine-2,5-diyldipropan-1-amines. .